[
  {
    "ts": null,
    "headline": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors",
    "summary": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1a197a3d2f50dcdb1aff6272cdc5bcd1617430849b913a8bde82486e93013890",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754412540,
      "headline": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors",
      "id": 136256541,
      "image": "",
      "related": "BDX",
      "source": "MarketWatch",
      "summary": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1a197a3d2f50dcdb1aff6272cdc5bcd1617430849b913a8bde82486e93013890"
    }
  },
  {
    "ts": null,
    "headline": "Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?",
    "summary": "BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.",
    "url": "https://finnhub.io/api/news?id=b38b302b1f455548746465b927be3bac2de3c546c23522a5004604e553fb50dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754410560,
      "headline": "Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?",
      "id": 136215099,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.",
      "url": "https://finnhub.io/api/news?id=b38b302b1f455548746465b927be3bac2de3c546c23522a5004604e553fb50dc"
    }
  },
  {
    "ts": null,
    "headline": "Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer",
    "summary": "Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Sean Boyle as Chief Executive Officer.",
    "url": "https://finnhub.io/api/news?id=ecf2e3048c3c4f7fb0ca0b46566d0a6c890f7c7a16a8920ab6fbf6197aa3ae98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754395320,
      "headline": "Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer",
      "id": 136212592,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Sean Boyle as Chief Executive Officer.",
      "url": "https://finnhub.io/api/news?id=ecf2e3048c3c4f7fb0ca0b46566d0a6c890f7c7a16a8920ab6fbf6197aa3ae98"
    }
  },
  {
    "ts": null,
    "headline": "BD announces $35m investment to expand prefilled syringe manufacturing in US",
    "summary": "The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.",
    "url": "https://finnhub.io/api/news?id=9fd4b2352c292410351cc0858853adab453208a0d7d1ff3f284871c01b5b06ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754392061,
      "headline": "BD announces $35m investment to expand prefilled syringe manufacturing in US",
      "id": 136212593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.",
      "url": "https://finnhub.io/api/news?id=9fd4b2352c292410351cc0858853adab453208a0d7d1ff3f284871c01b5b06ce"
    }
  },
  {
    "ts": null,
    "headline": "BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative's (HIRC) Resiliency Badging program.",
    "url": "https://finnhub.io/api/news?id=83d7007a49d0dc4d2d9b49ec69605d30e5c814e4ab36faff9f45f6471aed207a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391000,
      "headline": "BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories",
      "id": 136212594,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative's (HIRC) Resiliency Badging program.",
      "url": "https://finnhub.io/api/news?id=83d7007a49d0dc4d2d9b49ec69605d30e5c814e4ab36faff9f45f6471aed207a"
    }
  }
]